GoldenGolden
Advanced Search
Adage Capital Management

Adage Capital Management

A Boston based capital management firm founded in 2001 by Phillip Gross and Robert George Atchinson.

Adage Capital Management is a Boston based capital management firm founded in 2001 by Phillip Gross and Robert George Atchinson.

The firm has $8.9B under its management and focuses on managing S&P 500 assets mainly for Endowments and Foundations. The firm invests in early-stage and late-stage ventures.

The notable investment portfolio of Adage Capital Management includes, MedAvail, Annexon Biosciences, Cabaletta Bio, GitLab, Precision BioSciences, Prevail Therapeutics, Scout Bio, and Tanium.

As of January 2020, Adage Capital Management has made 41 investments and had 28 exits.

Timeline

People

Name
Role
LinkedIn

Phillip Gross

Co-Founder, Managing Director & Portfolio Manage

Daniel Joseph Lehan

Chief Operating Officer and Chief Compliance Officer

Josh Kagel

Employee

Ken Gawrelski

Employee

Michael Gants

Employee

Robert George Atchinson

Co-Founder, Managing Director, and Portfolio Manager

Sanjey Sivanesan

Employee

Stephen BArker

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

MedAvail

Annexon Biosciences

Cabaletta Bio

GitLab

Precision BioSciences

Prevail Therapeutics

Scout Bio

Tanium

News

Title
Author
Date
Publisher
Description
Alex Keown
April 13, 2021
BioSpace
This morning, multiple companies announced hundreds of millions of dollars were raised in Series B rounds that will be used to advance therapeutics and business development programs.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.